Contact us
We are a company developing allogeneic CAR-T cells to treat refractory diseases represented by advanced solid tumors.
Ningbo, Suzhou, Chongqing
Hong Kong, United States
INVEST@t-maximum.com
PR@t-maximum.com
T-MAXIMUM PHARMACEUTICAL
Ningbo
Suzhou
Chongqing
Hongkong
USA• San Francisco